1-8 of 8
Piero De Stefano
Close
Sort by
Journal Articles

Cardiac morbidity and mortality in deferoxamine- or deferiprone-treated patients with thalassemia major

Clinical Trials & Observations
Caterina Borgna-Pignatti, Maria Domenica Cappellini, Piero De Stefano, Giovanni Carlo Del Vecchio, Gian Luca Forni, Maria Rita Gamberini, Roberta Ghilardi, Antonio Piga, Maria Antonietta Romeo, Huaqing Zhao, Avital Cnaan
Journal: Blood
Blood (2006) 107 (9): 3733–3737.
https://doi.org/10.1182/blood-2005-07-2933
Published: 2006
Journal Articles

Graft rejection after unrelated donor hematopoietic stem cell transplantation for thalassemia is associated with nonpermissive HLA-DPB1 disparity in host-versus-graft direction

Clinical Trials & Observations
Katharina Fleischhauer, Franco Locatelli, Marco Zecca, Maria Grazia Orofino, Claudio Giardini, Piero De Stefano, Andrea Pession, Angela Maria Iannone, Carlo Carcassi, Elisabetta Zino, Giorgio La Nasa
Journal: Blood
Blood (2006) 107 (7): 2984–2992.
https://doi.org/10.1182/blood-2005-08-3374
Published: 2006
Journal Articles

T Cell-Mediated Control of HCMV Infection in Pediatric Patients Receiving Hematopoietic Stem Cell Transplantation.

Franco Locatelli, MD, Daniele Lilleri, MD, Laura Lozza, PhD, Giovanna Giorgiani, MD, Piero De Stefano, MD, Chiara Fornara, PhD, Stefania Telli, MD, Rita Maccario, PhD, Maria Grazia Revello, MD, Giuseppe Gerna, MD
Journal: Blood
Blood (2004) 104 (11): 5087.
https://doi.org/10.1182/blood.V104.11.5087.5087
Published: 2004
Journal Articles

Reconstitution dynamics of plasmacytoid and myeloid dendritic cell precursors after allogeneic myeloablative hematopoietic stem cell transplantation

Francesco F. Fagnoni, Barbara Oliviero, Giovanna Giorgiani, Piero De Stefano, Anna Dehò, Carlo Zibera, Nadia Gibelli, Rita Maccario, GianAntonio Da Prada, Marco Zecca, Franco Locatelli
Journal: Blood
Blood (2004) 104 (1): 281–289.
https://doi.org/10.1182/blood-2003-07-2443
Published: 2004
Journal Articles

Human cytomegalovirus immediate-early mRNAemia versus pp65 antigenemia for guiding pre-emptive therapy in children and young adults undergoing hematopoietic stem cell transplantation: a prospective, randomized, open-label trial

Clinical Trials & Observations
Giuseppe Gerna, Daniele Lilleri, Fausto Baldanti, Maria Torsellini, Giovanna Giorgiani, Marco Zecca, Piero De Stefano, Jaap Middeldorp, Franco Locatelli, M. Grazia Revello
Journal: Blood
Blood (2003) 101 (12): 5053–5060.
https://doi.org/10.1182/blood-2002-12-3636
Published: 2003
Journal Articles

Rituximab for the treatment of refractory autoimmune hemolytic anemia in children

Clinical Trials & Observations
Marco Zecca, Bruno Nobili, Ugo Ramenghi, Silverio Perrotta, Giovanni Amendola, Pasquale Rosito, Momcilo Jankovic, Paolo Pierani, Piero De Stefano, Mario Regazzi Bonora, Franco Locatelli
Journal: Blood
Blood (2003) 101 (10): 3857–3861.
https://doi.org/10.1182/blood-2002-11-3547
Published: 2003
Journal Articles

Unrelated donor bone marrow transplantation for thalassemia: the effect of extended haplotypes

Clinical Trials & Observations
Giorgio La Nasa, Claudio Giardini, Francesca Argiolu, Franco Locatelli, Marcella Arras, Piero De Stefano, Antonio Ledda, Antonella Pizzati, Maria A. Sanna, Adriana Vacca, Guido Lucarelli, Licinio Contu
Journal: Blood
Blood (2002) 99 (12): 4350–4356.
https://doi.org/10.1182/blood.V99.12.4350
Published: 2002
Journal Articles

Anti-CD20 monoclonal antibody for the treatment of severe, immune-mediated, pure red cell aplasia and hemolytic anemia

Brief Report
Marco Zecca, Piero De Stefano, Bruno Nobili, Franco Locatelli
Journal: Blood
Blood (2001) 97 (12): 3995–3997.
https://doi.org/10.1182/blood.V97.12.3995
Published: 2001